A Tunable Brake for HECT Ubiquitin Ligases

Area of Science:

• Biochemistry
• Molecular Biology
• Structural Biology

Background:

• HECT E3 ligases control protein ubiquitination, a process critical for cellular function.
• Dysregulation of HECT E3 ligase activity is implicated in cancer and immune disorders.
• Understanding HECT E3 ligase regulation is crucial for disease prevention and treatment.

Purpose of the Study:

• To investigate the regulatory role of peptide linkers in HECT E3 ligase activity.
• To elucidate the structural and biochemical mechanisms underlying linker-mediated inhibition.
• To explore the impact of post-translational modifications on HECT E3 ligase function.

Main Methods:

• Biochemical assays to measure catalytic activity.
• Structural analyses to determine protein conformation.
• Cellular studies to assess in vivo function and regulation.

Main Results:

• Peptide linkers tethering WW domains act as key regulatory elements in HECT E3 ligases.
• Linkers inhibit HECT domain activity by locking it in an inactive conformation and blocking ubiquitin binding.
• Linker post-translational modifications can relieve autoinhibition, but excessive removal leads to hyperactivation and self-destruction.

Conclusions:

• Linker-mediated autoinhibition is a critical mechanism for controlling HECT E3 ligase activity.
• These findings clarify mechanisms of cancer-associated HECT mutations.
• A new framework for understanding HECT E3 ligase fine-tuning in cellular behavior is provided.